Abstract

PCV7 use in the U.S. has led to notable decreases in invasive pneumococcal disease (IPD). We examined PCV7 influence on IPD mortality for all age groups using National Multiple-Cause-of-Death data (1990–2005). Age-specific mortality rates were compared before and after PCV7 use. Average decreases in age-adjusted mortality rates for meningitis and septicemia accelerated post-PCV7, the greatest decline observed in septicemia-related deaths. The youngest and oldest age groups experienced large decreases in age-specific mortality rates after the introduction of PCV7. Mortality rate decline across all age groups strengthens evidence of vaccine-induced herd immunity and provides additional information for cost–benefit analyses of PCV7.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.